Development and Validation of a Fully Automated Platform for Extended Blood Group Genotyping.
J Mol Diagn
; 18(1): 144-52, 2016 Jan.
Article
em En
| MEDLINE
| ID: mdl-26621100
ABSTRACT
Thirty-five blood group systems, containing >300 antigens, are listed by the International Society of Blood Transfusion. Most of these antigens result from a single nucleotide polymorphism. Blood group typing is conventionally performed by serology. However, this technique has some limitations and cannot respond to the growing demand of blood products typed for a large number of antigens. The knowledge of the molecular basis of these red blood cell systems allowed the implementation of molecular biology methods in immunohematology laboratories. Here, we describe a blood group genotyping assay based on the use of TKL immobilization support and microarray-based HIFI technology that takes approximately 4 hours and 30 minutes from whole-blood samples to results analysis. Targets amplified by multiplex PCR were hybridized on the chip, and a revelation step allowed the simultaneous identification of up to 24 blood group antigens, leading to the determination of extended genotypes. Two panels of multiplex PCR were developed Panel 1 (KEL1/2, KEL3/4; JK1/2; FY1/2; MNS1/2, MNS3/4, FY*Fy et FY*X) and Panel 2 (YT1/2; CO1/2; DO1/2, HY+, Jo(a+); LU1/2; DI1/2). We present the results of the evaluation of our platform on a panel of 583 and 190 blood donor samples for Panel 1 and 2, respectively. Good correlations (99% to 100%) with reference were obtained.
Texto completo:
1
Base de dados:
MEDLINE
Assunto principal:
Antígenos de Grupos Sanguíneos
/
Tipagem e Reações Cruzadas Sanguíneas
/
Técnicas de Genotipagem
Idioma:
En
Ano de publicação:
2016
Tipo de documento:
Article